首页> 美国卫生研究院文献>Journal of Enzyme Inhibition and Medicinal Chemistry >Novel Re(I) tricarbonyl coordination compounds based on 2-pyridyl-123-triazole derivatives bearing a 4-amino-substituted benzenesulfonamide arm: synthesis crystal structure computational studies and inhibitory activity against carbonic anhydrase I II and IX isoforms†
【2h】

Novel Re(I) tricarbonyl coordination compounds based on 2-pyridyl-123-triazole derivatives bearing a 4-amino-substituted benzenesulfonamide arm: synthesis crystal structure computational studies and inhibitory activity against carbonic anhydrase I II and IX isoforms†

机译:基于带有4-氨基取代的苯磺酰胺臂的2-吡啶基-123-三唑衍生物的新型Re(I)三羰基配位化合物:合成晶体结构计算研究和对碳酸酐酶III和IX亚型†

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this work, two bidentate 2-pyridyl-1,2,3-triazole ligands (>3a and >3b) containing a 4-substituted benzenesulfonamide pharmacophore prepared by classical click chemistry procedures, as well as their corresponding rhenium complexes, >4a and >4b of general formula [ReCl(CO)3(>L)] (>L => 3a or >3b) were prepared and fully characterised by spectroscopic methods (IR, NMR, MS, UV-Vis), elemental analysis, X-ray diffraction, and theoretical studies using DFT and TD-DFT methods. In particular, we showed that, in the solid state, the pyridine and the triazole rings of >3b adopted an uncommon cis configuration which stems from intermolecular hydrogen bonds. Preliminary assays demonstrated a promising nanomolar inhibitory activity against carbonic anhydrase isoform IX for both ligands and complexes with a strong affinity Ki of 2.8 nM for ligand >3a. More interestingly, complex >4b exhibited a pronounced selectivity against hCA IX over the off-targets hCA I and hCA II which makes this compound a promising potential anticancer drug candidate.
机译:在这项工作中,通过经典点击化学方法制备了含有4-取代的苯磺酰胺药效基团的两个二齿2-吡啶基-1,2,3-三唑配体(> 3a 和> 3b ) ,以及它们相应的complex络合物,通式为[ReCl(CO)3(> L )](>的> 4a 和> 4b 制备了L = > 3a 或> 3b ),并通过光谱方法(IR,NMR,MS,UV-Vis),元素分析,X射线进行了全面表征衍射,以及使用DFT和TD-DFT方法的理论研究。尤其是,我们表明,在固态下,> 3b 的吡啶和三唑环具有不常见的顺式构型,该构型源自分子间的氢键。初步测定表明,对碳酸酐酶同工型IX的配体和配合物均具有良好的纳摩尔抑制活性,对配体> 3a 的亲和力为2.8 nM。更有趣的是,复合物> 4b 对脱靶hCA I和hCA II表现出明显的针对hCA IX的选择性,这使该化合物成为有希望的潜在抗癌药物候选物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号